A hallmark of Parkinson's disease is the buildup of Lewy bodies—misfolded clumps of the protein known as alpha-synuclein.

Coya Therapeutics raised $11.1 million to support manufacturing scale-up for its experimental ALS therapy, COYA 302.

The ability to use language to communicate is one of things that makes us human. At MIT's McGovern Institute for Brain ...

Researchers at the University of Texas Medical Branch recently discovered a significant advancement in the fight against ...

For decades, researchers have attempted to pinpoint the specific areas of the brain responsible for human intelligence. A new ...

Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced ...

Neurodegenerative diseases (NDs) are among the most urgent global health challenges, affecting millions worldwide and placing a growing burden on healthcare ...

By Joe Manio Lethbridge Herald Speaking to the Southern Alberta Council on Public Affairs (SACPA) on Thursday, University of Lethbridge (U of L) ...

Outdoor air pollution is a combination of dangerous chemicals and gases stemming from various sources, such as wildfires and volcanic activity, to traffic and factories. This causes harmful pollutants ...

For decades, the search for the origins of memory loss has focused almost exclusively on two regions of the brain: the prefrontal cortex and the ...

Upregulated expression of transcription factors promoting cone identity in late-stage retinal progenitors drives development ...

Fluoxetine exposure during early auditory development drove 91 gene expression changes in the brainstem, reduced the stability of mature neural circuits, an ...